What is Eosinophilic Pneumonitis (EP), a type of pulmonary inflammation characterized by an increased number of eosinophils?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Eosinophilic pneumonitis is a rare disorder characterized by the accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid, which can be acute or chronic, and is typically treated with corticosteroids. The condition can be caused by various factors, including medications, parasitic infections, allergic reactions, or autoimmune disorders, and identifying and removing the underlying trigger is essential for long-term management 1. The diagnosis is confirmed through a combination of chest imaging, blood tests, and sometimes bronchoalveolar lavage or lung biopsy demonstrating eosinophilic infiltration.

Clinical Presentation

The clinical presentation of eosinophilic pneumonitis can vary, but common symptoms include:

  • Cough
  • Shortness of breath
  • Fever
  • Chest pain The condition can be life-threatening if left untreated, especially in cases of acute eosinophilic pneumonia, which often presents with acute respiratory failure 2.

Treatment

Treatment primarily involves corticosteroids, with prednisone typically started at 40-60mg daily for acute cases, then tapered over weeks to months 3. For chronic cases, longer treatment courses are often needed, sometimes lasting 6-12 months with a slow taper to prevent relapse. The duration of corticosteroid treatment can be shortened to 2 weeks, even in patients with respiratory failure, as shown in a study published in The European Respiratory Journal 3.

Prognosis

Most patients respond well to corticosteroid therapy within days to weeks, though some may require additional immunosuppressive medications if steroids alone are insufficient or poorly tolerated 4. Early and accurate diagnosis is imperative, as delayed diagnosis and treatment can lead to fatal lung disease. The prognosis is typically excellent provided treatment is initiated in a timely manner 4.

Key Points

  • Eosinophilic pneumonitis is a rare disorder characterized by the accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid.
  • The condition can be acute or chronic and is typically treated with corticosteroids.
  • Identifying and removing the underlying trigger is essential for long-term management.
  • Early and accurate diagnosis is imperative to prevent fatal lung disease.

References

Research

Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.

Allergology international : official journal of the Japanese Society of Allergology, 2019

Research

Pulmonary eosinophilia.

Clinical reviews in allergy & immunology, 2008

Research

Eosinophilic Pneumonias.

The journal of allergy and clinical immunology. In practice, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.